HCA Healthcare, Inc. (HCA.MX)
| Previous close | 5,222.70 |
| Open | 5,222.70 |
| Bid | 5,104.01 x 0 |
| Ask | 5,359.19 x 0 |
| Day's range | 5,222.70 - 5,222.70 |
| 52-week range | 4,032.82 - 5,475.92 |
| Volume | |
| Avg. volume | 138 |
| Market cap | 1.37T |
| Beta (5Y monthly) | 1.67 |
| PE ratio (TTM) | 15.41 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 45.43 (0.87%) |
| Ex-dividend date | 14 June 2024 |
| 1y target est | N/A |
- GlobeNewswire
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be
- Business Wire
HCA Healthcare Reports First Quarter 2024 Results
NASHVILLE, Tenn., April 26, 2024--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.
- GlobeNewswire
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departmentsSAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the cou
